Editorial Board
page ii
Full-Text PDF (14 KB)

The underdiagnosis of the vascular contribution to dementia
Amos D. Korczyn
pages 3-6
Abstract | Full Text | Full-Text PDF (83 KB)

Cerebral small vessel disease: how does it progress?
Klaus Schmidtke, Michael Hüll
pages 13-20
Abstract | Full Text | Full-Text PDF (134 KB)

Noninfarct vascular dementia and Alzheimer dementia spectrum
V. Olga Emery, Edward X. Gillie, Joseph A. Smith
pages 27-36
Abstract | Full Text | Full-Text PDF (143 KB)

Survival following dementia onset: Alzheimer's disease and vascular dementia
Annette L. Fitzpatrick, Lewis H. Kuller, Oscar L. Lopez, Claudia H. Kawas, William Jagust
pages 43-49
Abstract | Full Text | Full-Text PDF (254 KB)

Understanding the pathology of vascular cognitive impairment
Kurt A. Jellinger
pages 57-63
Abstract | Full Text | Full-Text PDF (125 KB)

Methods of detecting potential causes of vascular cognitive impairment after coronary artery bypass grafting
David Russell, Nathan Bornstein
pages 69-73
Abstract | Full Text | Full-Text PDF (327 KB)

From trepidant abasia to motor network failure—gait disorders as a consequence of subcortical vascular encephalopathy (SVE) Review of historical and contemporary concepts
Hansjoerg Baezner, Michael Hennerici
pages 81-88
Abstract | Full Text | Full-Text PDF (241 KB)

Optimized neuropsychological procedures at different stages of dementia diagnostics
Marinella Damian, Markus Kreis, Bertram Krumm, Frank Hentschel
pages 95-101
Abstract | Full Text | Full-Text PDF (171 KB)

Effects of arousing emotional scenes on the distribution of visuospatial attention: changes with aging and early subcortical vascular dementia
A. Rösler, C. Ulrich, J. Billino, P. Sterzer, S. Weidauer, T. Bernhardt, H. Steinmetz, L. Frölich, A. Kleinschmidt
pages 109-116
Abstract | Full Text | Full-Text PDF (353 KB)

MRI identifies MCI subtypes: vascular versus neurodegenerative
John S. Meyer, Minh Quach, John Thornby, Munir Chowdhury, Juebin Huang
pages 121-129
Abstract | Full Text | Full-Text PDF (393 KB)

Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials
A. Peter Passmore, Anthony J. Bayer, Elisabeth Steinhagen-Thiessen
pages 141-146
Abstract | Full Text | Full-Text PDF (228 KB)

Does blood pressure lowering treatment prevents dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease?
Valery Feigin, Yogini Ratnasabapathy, Craig Anderson
pages 151-155
Abstract | Full Text | Full-Text PDF (224 KB)

Aspirin resistance in stroke: 2004
Laszlo K. Sztriha, Katalin Sas, Laszlo Vecsei
pages 163-169
Abstract | Full Text | Full-Text PDF (126 KB)

Hypocitrullinemia in patients with MELAS: an insight into the “MELAS paradox”
Ali Naini, Petra Kaufmann, Sara Shanske, Kristin Engelstad, Darryl C. De Vivo, Eric A. Schon
pages 187-193
Abstract | Full Text | Full-Text PDF (232 KB)

Understanding regulation of nerve cell death by mGluRs as a method for development of successful neuroprotective strategies
Andrius Baskys, Morten Blaabjerg
pages 201-209
Abstract | Full Text | Full-Text PDF (316 KB)

Anti-heparan sulphate antibodies and homocysteine in dementia: markers of vascular pathology?
Chiara Briani, Annachiara Cagnin, Livia Gallo, Elisabetta Toffanin, Mariacristina Varagnolo, Martina Zaninotto, Mario Plebani, Gianluigi Ricchieri, Leontino Battistin, Gilberto Pizzolato
pages 215-218
Abstract | Full Text | Full-Text PDF (134 KB)

Murine synaptosomal lipid raft protein and lipid composition are altered by expression of human apoE 3 and 4 and by increasing age
U. Igbavboa, G.P. Eckert, T.M. Malo, A.E. Studniski, L.N.A. Johnson, N. Yamamoto, M. Kobayashi, S.C. Fujita, T.R. Appel, W.E. Müller, W.G. Wood, K. Yanagisawa
pages 225-232
Abstract | Full Text | Full-Text PDF (352 KB)

Brain area- and isoform-specific inhibition of synaptic plasticity by apoE4
Ofir Levi, Ana L. Jongen-Relo, Joram Feldon, Daniel M. Michaelson
pages 241-248
Abstract | Full Text | Full-Text PDF (444 KB)

Non-human primate SPECT model for determining cerebral perfusion effects of cerebrovasoactive drugs acting via multiple modes of pharmacological action
Douglas W. Oliver, Irene C. Dormehl, Werner K.A. Louw
pages 255-259
Abstract | Full Text | Full-Text PDF (1087 KB)

The regulation of β-secretase by cholesterol and statins in Alzheimer's disease
Christina Sidera, Richard Parsons, Brian Austen
pages 269-273
Abstract | Full Text | Full-Text PDF (186 KB)

Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease
Ali Aliyev, Shu G. Chen, Dilara Seyidova, Mark A. Smith, George Perry, Jack de la Torre, Gjumrakch Aliev
pages 285-292
Abstract | Full Text | Full-Text PDF (925 KB)

Calendar of Events
page 385
Full-Text PDF (48 KB)